Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Am I Out Of Line Here?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(286)
•••
Post by beenthereon Jan 17, 2023 9:32pm
263 Views
Post# 35229617

Am I Out Of Line Here?

Am I Out Of Line Here?Am I am  out of line here?

Does any of this  make any sense?

These last 2 posts from JD has made me say what has been on my mind.

I have been here for at least a decade and have done battle with JD all that time!

To me imo JD has" lived" Bioasis all that time as super supporter so why the change?

Why would he go a 180 at this time?

I think JD is a con! I think JD is  still working for BTI and an inside plant to gets us to go along with this  
deal. Why such a turn about in such a short time? Even JDcannot read 400 pages and form an opinion that quickly!

JD is  NOT your friend!

NO even if it means the end!

JD , you should be ashamed but I guess when left with little choice ....
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities